TreeWAS – Variant ID: rs13194491

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E83.1 Disorders of iron metabolism	1.000	0.000	0.000
G35 Multiple sclerosis	1.000	0.000	0.000
Chapter VI Diseases of the nervous system	1.000	0.000	0.000
G35-G37 Demyelinating diseases of the central nervous system	1.000	0.000	0.000
# Top node	0.999	0.001	0.000
Chapter XII Diseases of the skin and subcutaneous tissue	0.999	0.001	0.000
K70-K77 Diseases of liver	0.998	0.002	0.000
L00-L08 Infections of the skin and subcutaneous tissue	0.997	0.003	0.000
K74 Fibrosis and cirrhosis of liver	0.996	0.004	0.000
L03 Cellulitis	0.993	0.007	0.000
L03.1 Cellulitis of other parts of limb	0.993	0.007	0.000
Chapter XX External causes of morbidity and mortality	0.992	0.008	0.000
K76 Other diseases of liver	0.991	0.009	0.000
Chapter XI Diseases of the digestive system	0.989	0.011	0.000
K70 Alcoholic liver disease	0.985	0.015	0.000
K76.6 Portal hypertension	0.978	0.022	0.000
K74.6 Other and unspecified cirrhosis of liver	0.972	0.028	0.000
L02 Cutaneous abscess, furuncle and carbuncle	0.970	0.030	0.000
E83 Disorders of mineral metabolism	0.969	0.031	0.000
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.964	0.036	0.000
E70-E90 Metabolic disorders	0.964	0.036	0.000
Chapter IV Endocrine, nutritional and metabolic diseases	0.961	0.039	0.000
L02.2 Cutaneous abscess, furuncle and carbuncle of trunk	0.959	0.041	0.000
W00-W19 Falls	0.957	0.043	0.000
K74.0 Hepatic fibrosis	0.955	0.045	0.000
G30-G32 Other degenerative diseases of the nervous system	0.952	0.048	0.000
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified	0.948	0.052	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.945	0.055	0.000
Q20-Q28 Congenital malformations of the circulatory system	0.936	0.064	0.000
K50-K52 Noninfective enteritis and colitis	0.929	0.071	0.000
K51 Ulcerative colitis	0.924	0.076	0.000
K76.0 Fatty (change of) liver, not elsewhere classified	0.923	0.077	0.000
K70.0 Alcoholic fatty liver	0.920	0.080	0.000
W19 Unspecified fall	0.918	0.082	0.000
Chapter V Mental and behavioural disorders	0.918	0.082	0.000
Q80-Q89 Other congenital malformations	0.912	0.088	0.000
G30 Alzheimer's disease	0.903	0.097	0.000
L20-L30 Dermatitis and eczema	0.894	0.106	0.000
V40-V49 Car occupant injured in transport accident	0.888	0.112	0.000
W19.4 Street and highway	0.886	0.114	0.000
K70.3 Alcoholic cirrhosis of liver	0.885	0.115	0.000
G20-G26 Extrapyramidal and movement disorders	0.885	0.115	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.880	0.120	0.000
K74.3 Primary biliary cirrhosis	0.877	0.123	0.000
V10-V19 Pedal cyclist injured in transport accident	0.876	0.124	0.000
E80 Disorders of porphyrin and bilirubin metabolism	0.875	0.125	0.000
L50-L54 Urticaria and erythema	0.875	0.125	0.000
K51.3 Ulcerative (chronic) rectosigmoiditis	0.874	0.126	0.000
E89.0 Postprocedural hypothyroidism	0.873	0.127	0.000
F00-F09 Organic, including symptomatic, mental disorders	0.865	0.135	0.000
K70.2 Alcoholic fibrosis and sclerosis of liver	0.862	0.138	0.000
L03.2 Cellulitis of face	0.842	0.158	0.000
K70.4 Alcoholic hepatic failure	0.842	0.158	0.000
Q25 Congenital malformations of great arteries	0.841	0.159	0.000
E89.2 Postprocedural hypoparathyroidism	0.840	0.160	0.000
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue	0.837	0.163	0.000
Q23 Congenital malformations of aortic and mitral valves	0.835	0.165	0.000
W17 Other fall from one level to another	0.825	0.175	0.000
I83.9 Varicose veins of lower extremities without ulcer or inflammation	0.823	0.177	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.820	0.180	0.000
Q24 Other congenital malformations of heart	0.818	0.182	0.000
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors	0.816	0.184	0.000
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.813	0.187	0.000
Y40 Systemic antibiotics	0.813	0.187	0.000
Y44 Agents primarily affecting blood constituents	0.812	0.188	0.000
Q89 Other congenital malformations, not elsewhere classified	0.810	0.190	0.000
I83 Varicose veins of lower extremities	0.809	0.191	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.807	0.193	0.000
K65-K67 Diseases of peritoneum	0.803	0.197	0.000
L60-L75 Disorders of skin appendages	0.800	0.200	0.000
G30.9 Alzheimer's disease, unspecified	0.800	0.200	0.000
Chapter IX Diseases of the circulatory system	0.795	0.205	0.000
K51.2 Ulcerative (chronic) proctitis	0.792	0.208	0.000
L30 Other dermatitis	0.792	0.208	0.000
G00-G09 Inflammatory diseases of the central nervous system	0.791	0.209	0.000
K51.4 Pseudopolyposis of colon	0.791	0.209	0.000
E80.1 Porphyria cutanea tarda	0.789	0.211	0.000
I80-I89 Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified	0.789	0.211	0.000
W19.9 Unspecified place	0.787	0.213	0.000
E89.3 Postprocedural hypopituitarism	0.785	0.215	0.000
L02.0 Cutaneous abscess, furuncle and carbuncle of face	0.784	0.216	0.000
G37 Other demyelinating diseases of central nervous system	0.781	0.219	0.000
G30.0 Alzheimer's disease with early onset	0.780	0.220	0.000
F60-F69 Disorders of adult personality and behaviour	0.779	0.221	0.000
V80-V89 Other land transport accidents	0.779	0.221	0.000
G40-G47 Episodic and paroxysmal disorders	0.779	0.221	0.000
K51.5 Mucosal proctocolitis	0.775	0.225	0.000
E89.6 Postprocedural adrenocortical(-medullary) hypofunction	0.775	0.225	0.000
F00 Dementia in Alzheimer's disease	0.775	0.225	0.000
K51.0 Ulcerative (chronic) enterocolitis	0.775	0.225	0.000
W18 Other fall on same level	0.775	0.225	0.000
V70-V79 Bus occupant injured in transport accident	0.774	0.226	0.000
Q82 Other congenital malformations of skin	0.773	0.227	0.000
L03.8 Cellulitis of other sites	0.770	0.230	0.000
G24 Dystonia	0.769	0.231	0.000
V49 Car occupant injured in other and unspecified transport accidents	0.767	0.233	0.000
L02.3 Cutaneous abscess, furuncle and carbuncle of buttock	0.767	0.233	0.000
L02.1 Cutaneous abscess, furuncle and carbuncle of neck	0.766	0.234	0.000
G31 Other degenerative diseases of nervous system, not elsewhere classified	0.764	0.236	0.000
X50-X57 Overexertion, travel and privation	0.763	0.237	0.000
W50-W64 Exposure to animate mechanical forces	0.762	0.238	0.000
X00-X09 Exposure to smoke, fire and flames	0.762	0.238	0.000
F99-F99 Unspecified mental disorder	0.760	0.240	0.000
I26-I28 Pulmonary heart disease and diseases of pulmonary circulation	0.760	0.240	0.000
X58-X59 Accidental exposure to other and unspecified factors	0.758	0.242	0.000
F10-F19 Mental and behavioural disorders due to psychoactive substance use	0.756	0.244	0.000
K65 Peritonitis	0.752	0.248	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.752	0.248	0.000
G40 Epilepsy	0.747	0.253	0.000
V18 Pedal cyclist injured in noncollision transport accident	0.746	0.254	0.000
V48 Car occupant injured in noncollision transport accident	0.741	0.258	0.000
Y45.5 4-Aminophenol derivatives	0.741	0.259	0.000
G70-G73 Diseases of myoneural junction and muscle	0.739	0.261	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.738	0.262	0.000
Q89.2 Congenital malformations of other endocrine glands	0.738	0.262	0.000
Y00-Y09 Assault	0.737	0.263	0.000
Y49.2 Other and unspecified antidepressants	0.736	0.264	0.000
L60 Nail disorders	0.736	0.264	0.000
W01 Fall on same level from slipping, tripping and stumbling	0.735	0.265	0.000
K00-K14 Diseases of oral cavity, salivary glands and jaws	0.734	0.266	0.000
Q23.1 Congenital insufficiency of aortic valve	0.730	0.270	0.000
Q27 Other congenital malformations of peripheral vascular system	0.729	0.271	0.000
Q90-Q99 Chromosomal abnormalities, not elsewhere classified	0.725	0.275	0.000
Y40.0 Penicillins	0.722	0.278	0.000
L20 Atopic dermatitis	0.722	0.278	0.000
G80-G83 Cerebral palsy and other paralytic syndromes	0.722	0.278	0.000
Q24.8 Other specified congenital malformations of heart	0.721	0.279	0.000
L53 Other erythematous conditions	0.721	0.279	0.000
X10-X19 Contact with heat and hot substances	0.721	0.279	0.000
G30.8 Other Alzheimer's disease	0.720	0.280	0.000
W15 Fall from cliff	0.720	0.280	0.000
F01 Vascular dementia	0.720	0.280	0.000
K76.7 Hepatorenal syndrome	0.720	0.280	0.000
Y45.0 Opioids and related analgesics	0.720	0.280	0.000
G40.6 Grand mal seizures, unspecified (with or without petit mal)	0.719	0.281	0.000
Q25.1 Coarctation of aorta	0.718	0.282	0.000
Q87 Other specified congenital malformation syndromes affecting multiple systems	0.718	0.282	0.000
G36 Other acute disseminated demyelination	0.717	0.283	0.000
Chapter XVI Certain conditions originating in the perinatal period	0.717	0.283	0.000
L10-L14 Bullous disorders	0.716	0.284	0.000
Chapter XXII Codes for special purposes	0.716	0.284	0.000
K77 Liver disorders in diseases classified elsewhere	0.715	0.284	0.000
K71 Toxic liver disease	0.715	0.284	0.000
L04 Acute lymphadenitis	0.715	0.285	0.000
L01 Impetigo	0.715	0.285	0.000
L00 Staphylococcal scalded skin syndrome	0.715	0.285	0.000
K74.4 Secondary biliary cirrhosis	0.714	0.286	0.000
K74.2 Hepatic fibrosis with hepatic sclerosis	0.714	0.286	0.000
K74.1 Hepatic sclerosis	0.714	0.286	0.000
L57 Skin changes due to chronic exposure to nonionising radiation	0.713	0.286	0.000
Y35-Y36 Legal intervention and operations of war	0.711	0.289	0.000
Y10-Y34 Event of undetermined intent	0.711	0.289	0.000
X85-X99 Assault	0.711	0.289	0.000
X30-X39 Exposure to forces of nature	0.711	0.289	0.000
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.711	0.289	0.000
W75-W84 Other accidental threats to breathing	0.711	0.289	0.000
W65-W74 Accidental drowning and submersion	0.711	0.289	0.000
V98-V99 Other and unspecified transport accidents	0.711	0.289	0.000
V95-V97 Air and space transport accidents	0.711	0.289	0.000
V90-V94 Water transport accidents	0.711	0.289	0.000
V60-V69 Occupant of heavy transport vehicle injured in transport accident	0.711	0.289	0.000
V50-V59 Occupant of pick-up truck or van injured in transport accident	0.711	0.289	0.000
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident	0.711	0.289	0.000
V01-V09 Pedestrian injured in transport accident	0.711	0.289	0.000
K76.5 Hepatic veno-occlusive disease	0.711	0.289	0.000
K76.4 Peliosis hepatis	0.711	0.289	0.000
K76.3 Infarction of liver	0.711	0.289	0.000
K76.2 Central haemorrhagic necrosis of liver	0.711	0.289	0.000
K76.1 Chronic passive congestion of liver	0.711	0.289	0.000
Q25.6 Stenosis of pulmonary artery	0.710	0.290	0.000
W17.4 Street and highway	0.708	0.292	0.000
W10 Fall on and from stairs and steps	0.708	0.292	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.707	0.293	0.000
K65.0 Acute peritonitis	0.706	0.294	0.000
K72 Hepatic failure, not elsewhere classified	0.706	0.294	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.706	0.294	0.000
K76.9 Liver disease, unspecified	0.704	0.296	0.000
L50 Urticaria	0.704	0.296	0.000
L30.9 Dermatitis, unspecified	0.701	0.299	0.000
K70.1 Alcoholic hepatitis	0.700	0.300	0.000
X60-X84 Intentional self-harm	0.700	0.300	0.000
G90-G99 Other disorders of the nervous system	0.699	0.301	0.000
Y54.7 Agents affecting calcification	0.698	0.302	0.000
L02.8 Cutaneous abscess, furuncle and carbuncle of other sites	0.696	0.304	0.000
E83.9 Disorder of mineral metabolism, unspecified	0.695	0.305	0.000
E83.8 Other disorders of mineral metabolism	0.695	0.305	0.000
E83.2 Disorders of zinc metabolism	0.695	0.305	0.000
E83.0 Disorders of copper metabolism	0.695	0.305	0.000
I83.0 Varicose veins of lower extremities with ulcer	0.695	0.305	0.000
L28 Lichen simplex chronicus and prurigo	0.694	0.305	0.000
E80.4 Gilbert's syndrome	0.694	0.306	0.000
W06 Fall involving bed	0.692	0.308	0.000
Q35-Q37 Cleft lip and cleft palate	0.691	0.309	0.000
Q30-Q34 Congenital malformations of the respiratory system	0.691	0.309	0.000
V19 Pedal cyclist injured in other and unspecified transport accidents	0.691	0.309	0.000
E84 Cystic fibrosis	0.691	0.309	0.000
E79 Disorders of purine and pyrimidine metabolism	0.691	0.309	0.000
E77 Disorders of glycoprotein metabolism	0.691	0.309	0.000
E76 Disorders of glycosaminoglycan metabolism	0.691	0.309	0.000
E75 Disorders of sphingolipid metabolism and other lipid storage disorders	0.691	0.309	0.000
E72 Other disorders of amino-acid metabolism	0.691	0.309	0.000
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism	0.691	0.309	0.000
E70 Disorders of aromatic amino-acid metabolism	0.691	0.309	0.000
E90 Nutritional and metabolic disorders in diseases classified elsewhere	0.691	0.309	0.000
X40-X49 Accidental poisoning by and exposure to noxious substances	0.690	0.310	0.000
F10 Mental and behavioural disorders due to use of alcohol	0.690	0.310	0.000
K10 Other diseases of jaws	0.689	0.311	0.000
F52 Sexual dysfunction, not caused by organic disorder or disease	0.687	0.313	0.000
F50 Eating disorders	0.686	0.314	0.000
W16 Diving or jumping into water causing injury other than drowning or submersion	0.686	0.314	0.000
W14 Fall from tree	0.686	0.314	0.000
W12 Fall on and from scaffolding	0.686	0.314	0.000
W09 Fall involving playground equipment	0.686	0.314	0.000
W05 Fall involving wheelchair	0.686	0.314	0.000
W04 Fall while being carried or supported by other persons	0.686	0.314	0.000
W03 Other fall on same level due to collision with, or pushing by, another person	0.686	0.314	0.000
W00 Fall on same level involving ice and snow	0.686	0.314	0.000
G04 Encephalitis, myelitis and encephalomyelitis	0.683	0.317	0.000
G32 Other degenerative disorders of nervous system in diseases classified elsewhere	0.682	0.317	0.000
I26 Pulmonary embolism	0.682	0.318	0.000
Y44.2 Anticoagulants	0.681	0.319	0.000
Y45.8 Other analgesics and antipyretics	0.681	0.319	0.000
E89.9 Postprocedural endocrine and metabolic disorder, unspecified	0.679	0.321	0.000
E89.8 Other postprocedural endocrine and metabolic disorders	0.679	0.321	0.000
E89.5 Postprocedural testicular hypofunction	0.679	0.321	0.000
E89.4 Postprocedural ovarian failure	0.679	0.321	0.000
E89.1 Postprocedural hypoinsulinaemia	0.679	0.321	0.000
E85 Amyloidosis	0.679	0.321	0.000
L57.0 Actinic keratosis	0.679	0.321	0.000
L21 Seborrhoeic dermatitis	0.678	0.322	0.000
Y59 Other and unspecified vaccines and biological substances	0.677	0.322	0.000
Y58 Bacterial vaccines	0.677	0.322	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.677	0.322	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.677	0.322	0.000
L60.0 Ingrowing nail	0.677	0.323	0.000
E83.3 Disorders of phosphorus metabolism	0.676	0.324	0.000
G25 Other extrapyramidal and movement disorders	0.676	0.324	0.000
I27 Other pulmonary heart diseases	0.676	0.324	0.000
L51 Erythema multiforme	0.675	0.325	0.000
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.673	0.327	0.000
Q82.5 Congenital nonneoplastic naevus	0.673	0.327	0.000
F05 Delirium, not induced by alcohol and other psychoactive substances	0.673	0.327	0.000
Q83 Congenital malformations of breast	0.672	0.328	0.000
Q23.0 Congenital stenosis of aortic valve	0.672	0.328	0.000
Y54.4 Loop [high-ceiling] diuretics	0.672	0.328	0.000
Q26 Congenital malformations of great veins	0.671	0.329	0.000
Q22 Congenital malformations of pulmonary and tricuspid valves	0.671	0.329	0.000
Q20 Congenital malformations of cardiac chambers and connexions	0.671	0.329	0.000
F00.9 Dementia in Alzheimer's disease, unspecified	0.670	0.330	0.000
G20 Parkinson's disease	0.670	0.330	0.000
I87 Other disorders of veins	0.665	0.335	0.000
W11 Fall on and from ladder	0.664	0.335	0.000
V20-V29 Motorcycle rider injured in transport accident	0.664	0.336	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.663	0.337	0.000
V17 Pedal cyclist injured in collision with fixed or stationary object	0.662	0.337	0.000
K51.1 Ulcerative (chronic) ileocolitis	0.662	0.338	0.000
Y45.1 Salicylates	0.661	0.338	0.000
G10-G14 Systemic atrophies primarily affecting the central nervous system	0.660	0.339	0.000
F70-F79 Mental retardation	0.660	0.340	0.000
Q85 Phakomatoses, not elsewhere classified	0.659	0.341	0.000
W08 Fall involving other furniture	0.659	0.341	0.000
W19.8 Other specified place	0.658	0.342	0.000
W19.5 Trade and service area	0.658	0.342	0.000
W19.0 Home	0.658	0.342	0.000
W19.7 Farm	0.658	0.342	0.000
W19.6 Industrial and construction area	0.658	0.342	0.000
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.658	0.342	0.000
K74.5 Biliary cirrhosis, unspecified	0.658	0.342	0.000
Y40.9 Systemic antibiotic, unspecified	0.656	0.344	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.654	0.345	0.000
Q86 Congenital malformation syndromes due to known exogenous causes, not elsewhere classified	0.654	0.346	0.000
Q84 Other congenital malformations of integument	0.654	0.346	0.000
Q81 Epidermolysis bullosa	0.654	0.346	0.000
Q80 Congenital ichthyosis	0.654	0.346	0.000
Q50-Q56 Congenital malformations of genital organs	0.653	0.347	0.000
G24.3 Spasmodic torticollis	0.653	0.347	0.000
Y79 Orthopaedic devices associated with adverse incidents	0.652	0.348	0.000
K51.8 Other ulcerative colitis	0.651	0.349	0.000
F07 Personality and behavioural disorders due to brain disease, damage and dysfunction	0.650	0.349	0.000
E74 Other disorders of carbohydrate metabolism	0.650	0.350	0.000
K13 Other diseases of lip and oral mucosa	0.650	0.350	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.649	0.351	0.000
Q65-Q79 Congenital malformations and deformations of the musculoskeletal system	0.649	0.351	0.000
K51.9 Ulcerative colitis, unspecified	0.648	0.352	0.000
G30.1 Alzheimer's disease with late onset	0.647	0.353	0.000
F99 Mental disorder, not otherwise specified	0.647	0.353	0.000
X20-X29 Contact with venomous animals and plants	0.646	0.353	0.000
K10.2 Inflammatory conditions of jaws	0.646	0.354	0.000
I95-I99 Other and unspecified disorders of the circulatory system	0.644	0.356	0.000
W02 Fall involving ice-skates, skis, roller-skates or skateboards	0.643	0.356	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.643	0.356	0.000
F06 Other mental disorders due to brain damage and dysfunction and to physical disease	0.643	0.357	0.000
F80-F89 Disorders of psychological development	0.643	0.357	0.000
W19.2 School, other institution and public administrative area	0.641	0.359	0.000
L24 Irritant contact dermatitis	0.641	0.359	0.000
L23 Allergic contact dermatitis	0.641	0.359	0.000
L26 Exfoliative dermatitis	0.641	0.359	0.000
L22 Diaper [napkin] dermatitis	0.641	0.359	0.000
V49.4 Driver injured in collision with other and unspecified motor vehicles in traffic accident	0.639	0.360	0.000
Y48 Anaesthetics and therapeutic gases	0.638	0.362	0.000
L53.9 Erythematous condition, unspecified	0.638	0.362	0.000
V47 Car occupant injured in collision with fixed or stationary object	0.637	0.363	0.000
V46 Car occupant injured in collision with other nonmotor vehicle	0.637	0.363	0.000
V45 Car occupant injured in collision with railway train or railway vehicle	0.637	0.363	0.000
V43 Car occupant injured in collision with car, pick-up truck or van	0.637	0.363	0.000
V42 Car occupant injured in collision with two- or three-wheeled motor vehicle	0.637	0.363	0.000
V41 Car occupant injured in collision with pedal cycle	0.637	0.363	0.000
V40 Car occupant injured in collision with pedestrian or animal	0.637	0.363	0.000
L25 Unspecified contact dermatitis	0.636	0.363	0.000
V48.4 Person injured while boarding or alighting	0.636	0.363	0.000
W18.5 Trade and service area	0.635	0.364	0.000
G31.2 Degeneration of nervous system due to alcohol	0.635	0.365	0.000
W17.6 Industrial and construction area	0.635	0.365	0.000
G23 Other degenerative diseases of basal ganglia	0.634	0.366	0.000
G21 Secondary Parkinsonism	0.634	0.366	0.000
G26 Extrapyramidal and movement disorders in diseases classified elsewhere	0.634	0.366	0.000
G22 Parkinsonism in diseases classified elsewhere	0.634	0.366	0.000
E73 Lactose intolerance	0.634	0.366	0.000
V18.2 Unspecified pedal cyclist injured in nontraffic accident	0.633	0.366	0.000
W19.1 Residential institution	0.632	0.368	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.631	0.369	0.000
Y45.4 Antirheumatics	0.631	0.369	0.000
V80 Animal-rider or occupant of animal-drawn vehicle injured in transport accident	0.630	0.370	0.000
K14 Diseases of tongue	0.630	0.370	0.000
F10.0 Acute intoxication	0.630	0.370	0.000
Y73 Gastro-enterology and urology devices associated with adverse incidents	0.630	0.370	0.000
Y57 Other and unspecified drugs and medicaments	0.628	0.372	0.000
V16 Pedal cyclist injured in collision with other nonmotor vehicle	0.628	0.372	0.000
V15 Pedal cyclist injured in collision with railway train or railway vehicle	0.628	0.372	0.000
V14 Pedal cyclist injured in collision with heavy transport vehicle or bus	0.628	0.372	0.000
V13 Pedal cyclist injured in collision with car, pick-up truck or van	0.628	0.372	0.000
V12 Pedal cyclist injured in collision with two- or three-wheeled motor vehicle	0.628	0.372	0.000
V11 Pedal cyclist injured in collision with other pedal cycle	0.628	0.372	0.000
V10 Pedal cyclist injured in collision with pedestrian or animal	0.628	0.372	0.000
E80.7 Disorder of bilirubin metabolism, unspecified	0.628	0.372	0.000
E80.6 Other disorders of bilirubin metabolism	0.628	0.372	0.000
E80.5 Crigler-Najjar syndrome	0.628	0.372	0.000
E80.3 Defects of catalase and peroxydase	0.628	0.372	0.000
E80.2 Other porphyria	0.628	0.372	0.000
E80.0 Hereditary erythropoietic porphyria	0.628	0.372	0.000
Q28 Other congenital malformations of circulatory system	0.628	0.372	0.000
L60.8 Other nail disorders	0.627	0.373	0.000
L54 Erythema in diseases classified elsewhere	0.627	0.373	0.000
F69 Unspecified disorder of adult personality and behaviour	0.626	0.373	0.000
K06 Other disorders of gingiva and edentulous alveolar ridge	0.625	0.375	0.000
D70-D77 Other diseases of blood and blood-forming organs	0.624	0.376	0.000
G46 Vascular syndromes of brain in cerebrovascular diseases	0.624	0.376	0.000
X59 Exposure to unspecified factor	0.623	0.377	0.000
V44 Car occupant injured in collision with heavy transport vehicle or bus	0.622	0.378	0.000
E65-E68 Obesity and other hyperalimentation	0.621	0.379	0.000
V49.9 Car occupant [any] injured in unspecified traffic accident	0.621	0.379	0.000
D75 Other diseases of blood and blood-forming organs	0.621	0.379	0.000
F09 Unspecified organic or symptomatic mental disorder	0.620	0.380	0.000
F04 Organic amnesic syndrome, not induced by alcohol and other psychoactive substances	0.620	0.380	0.000
V78 Bus occupant injured in noncollision transport accident	0.618	0.382	0.000
Y45.2 Propionic acid derivatives	0.617	0.383	0.000
L52 Erythema nodosum	0.617	0.383	0.000
Q24.5 Malformation of coronary vessels	0.616	0.383	0.000
W13 Fall from, out of or through building or structure	0.616	0.384	0.000
F01.9 Vascular dementia, unspecified	0.616	0.384	0.000
Y60-Y69 Misadventures to patients during surgical and medical care	0.614	0.385	0.000
L56 Other acute skin changes due to ultraviolet radiation	0.614	0.386	0.000
L73 Other follicular disorders	0.613	0.387	0.000
I86 Varicose veins of other sites	0.613	0.387	0.000
Y47.1 Benzodiazepines	0.613	0.387	0.000
L40-L45 Papulosquamous disorders	0.613	0.387	0.001
G40.3 Generalised idiopathic epilepsy and epileptic syndromes	0.613	0.387	0.000
Q10-Q18 Congenital malformations of eye, ear, face and neck	0.612	0.388	0.000
G82 Paraplegia and tetraplegia	0.612	0.388	0.000
F60 Specific personality disorders	0.612	0.388	0.000
L70 Acne	0.612	0.388	0.000
D75.1 Secondary polycythaemia	0.612	0.388	0.000
L30.8 Other specified dermatitis	0.611	0.389	0.000
Q27.8 Other specified congenital malformations of peripheral vascular system	0.611	0.389	0.000
G37.3 Acute transverse myelitis in demyelinating disease of central nervous system	0.609	0.391	0.000
G06 Intracranial and intraspinal abscess and granuloma	0.609	0.391	0.000
F00.2 Dementia in Alzheimer's disease, atypical or mixed type	0.608	0.392	0.000
F02 Dementia in other diseases classified elsewhere	0.608	0.392	0.000
I70-I79 Diseases of arteries, arterioles and capillaries	0.606	0.394	0.000
G04.9 Encephalitis, myelitis and encephalomyelitis, unspecified	0.605	0.395	0.000
G60-G64 Polyneuropathies and other disorders of the peripheral nervous system	0.604	0.396	0.000
Q25.9 Congenital malformation of great arteries, unspecified	0.603	0.397	0.000
Q25.8 Other congenital malformations of great arteries	0.603	0.397	0.000
Q25.7 Other congenital malformations of pulmonary artery	0.603	0.397	0.000
Q25.5 Atresia of pulmonary artery	0.603	0.397	0.000
Q25.4 Other congenital malformations of aorta	0.603	0.397	0.000
Q25.3 Stenosis of aorta	0.603	0.397	0.000
Q25.2 Atresia of aorta	0.603	0.397	0.000
Q25.0 Patent ductus arteriosus	0.603	0.397	0.000
L59 Other disorders of skin and subcutaneous tissue related to radiation	0.600	0.400	0.000
L58 Radiodermatitis	0.600	0.400	0.000
L55 Sunburn	0.600	0.400	0.000
K14.0 Glossitis	0.599	0.401	0.000
F10.2 Dependence syndrome	0.599	0.401	0.000
L20.9 Atopic dermatitis, unspecified	0.599	0.401	0.000
Q23.9 Congenital malformation of aortic and mitral valves, unspecified	0.599	0.401	0.000
Q23.8 Other congenital malformations of aortic and mitral valves	0.599	0.401	0.000
Q23.4 Hypoplastic left heart syndrome	0.599	0.401	0.000
Q23.3 Congenital mitral insufficiency	0.599	0.401	0.000
Q23.2 Congenital mitral stenosis	0.599	0.401	0.000
F03 Unspecified dementia	0.598	0.402	0.000
F00.0 Dementia in Alzheimer's disease with early onset	0.598	0.402	0.000
G40.0 Localisation-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localised onset	0.597	0.403	0.000
W51 Striking against or bumped into by another person	0.597	0.403	0.000
X09 Exposure to unspecified smoke, fire and flames	0.596	0.404	0.000
K73 Chronic hepatitis, not elsewhere classified	0.596	0.404	0.000
L71 Rosacea	0.596	0.404	0.000
G24.8 Other dystonia	0.595	0.405	0.000
G31.9 Degenerative disease of nervous system, unspecified	0.594	0.405	0.000
E40-E46 Malnutrition	0.594	0.406	0.000
F52.2 Failure of genital response	0.594	0.406	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.593	0.406	0.000
X50 Overexertion and strenuous or repetitive movements	0.592	0.408	0.000
F64 Gender identity disorders	0.591	0.409	0.000
W17.9 Unspecified place	0.591	0.409	0.000
W17.8 Other specified place	0.591	0.409	0.000
W17.0 Home	0.591	0.409	0.000
W17.7 Farm	0.591	0.409	0.000
W17.5 Trade and service area	0.591	0.409	0.000
W17.3 Sports and athletics area	0.591	0.409	0.000
W17.2 School, other institution and public administrative area	0.591	0.409	0.000
W17.1 Residential institution	0.591	0.409	0.000
I26.9 Pulmonary embolism without mention of acute cor pulmonale	0.591	0.409	0.000
Y54.5 Other diuretics	0.589	0.411	0.000
Y49.9 Psychotropic drug, unspecified	0.588	0.412	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.588	0.412	0.000
Y49.7 Psychostimulants with abuse potential	0.588	0.412	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.588	0.412	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.588	0.412	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.588	0.412	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.588	0.412	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.588	0.412	0.000
Q24.9 Congenital malformation of the heart, unspecified	0.587	0.413	0.000
Q24.6 Congenital heart block	0.587	0.413	0.000
Q24.4 Congenital subaortic stenosis	0.587	0.413	0.000
Q24.3 Pulmonary infundibular stenosis	0.587	0.413	0.000
Q24.2 Cor triatriatum	0.587	0.413	0.000
Q24.1 Levocardia	0.587	0.413	0.000
Q24.0 Dextrocardia	0.587	0.413	0.000
G41 Status epilepticus	0.586	0.413	0.000
Q00-Q07 Congenital malformations of the nervous system	0.586	0.414	0.000
Y00 Assault by blunt object	0.586	0.414	0.000
G09 Sequelae of inflammatory diseases of central nervous system	0.586	0.414	0.000
F53 Mental and behavioural disorders associated with the puerperium, not elsewhere classified	0.585	0.415	0.000
F51 Nonorganic sleep disorders	0.585	0.415	0.000
F59 Unspecified behavioural syndromes associated with physiological disturbances and physical factors	0.585	0.415	0.000
F55 Abuse of non-dependence-producing substances	0.585	0.415	0.000
F54 Psychological and behavioural factors associated with disorders or diseases classified elsewhere	0.585	0.415	0.000
F15 Mental and behavioural disorders due to use of other stimulants, including caffeine	0.584	0.416	0.000
Y40.7 Antifungal antibiotics, systemically used	0.583	0.417	0.000
Y40.6 Rifamycins	0.583	0.417	0.000
Y40.5 Aminoglycosides	0.583	0.417	0.000
Y40.4 Tetracyclines	0.583	0.417	0.000
Y40.2 Chloramphenicol group	0.583	0.417	0.000
Y82 Other and unspecified medical devices associated with adverse incidents	0.583	0.417	0.000
Y81 General- and plastic-surgery devices associated with adverse incidents	0.583	0.417	0.000
Y80 Physical medicine devices associated with adverse incidents	0.583	0.417	0.000
Y78 Radiological devices associated with adverse incidents	0.583	0.417	0.000
Y77 Ophthalmic devices associated with adverse incidents	0.583	0.417	0.000
Y76 Obstetric and gynaecological devices associated with adverse incidents	0.583	0.417	0.000
Y75 Neurological devices associated with adverse incidents	0.583	0.417	0.000
Y74 General hospital and personal-use devices associated with adverse incidents	0.583	0.417	0.000
Y72 Otorhinolaryngological devices associated with adverse incidents	0.583	0.417	0.000
Y71 Cardiovascular devices associated with adverse incidents	0.583	0.417	0.000
Y70 Anaesthesiology devices associated with adverse incidents	0.583	0.417	0.000
F10.5 Psychotic disorder	0.582	0.417	0.000
K65.8 Other peritonitis	0.582	0.417	0.000
L29 Pruritus	0.582	0.418	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.582	0.418	0.000
Y44.7 Plasma substitutes	0.582	0.418	0.000
Y44.6 Natural blood and blood products	0.582	0.418	0.000
Y44.5 Thrombolytic drugs	0.582	0.418	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.582	0.418	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.582	0.418	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.582	0.418	0.000
G24.9 Dystonia, unspecified	0.582	0.418	0.000
I28 Other diseases of pulmonary vessels	0.581	0.419	0.000
Q89.9 Congenital malformation, unspecified	0.581	0.419	0.000
Q89.8 Other specified congenital malformations	0.581	0.419	0.000
Q89.7 Multiple congenital malformations, not elsewhere classified	0.581	0.419	0.000
Q89.4 Conjoined twins	0.581	0.419	0.000
Q89.3 Situs inversus	0.581	0.419	0.000
Q89.1 Congenital malformations of adrenal gland	0.581	0.419	0.000
Q89.0 Congenital malformations of spleen	0.581	0.419	0.000
I83.2 Varicose veins of lower extremities with both ulcer and inflammation	0.580	0.420	0.000
Y54.9 Mineral salts, not elsewhere classified	0.579	0.421	0.000
Y54.8 Agents affecting uric acid metabolism	0.579	0.421	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.579	0.421	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.579	0.421	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.579	0.421	0.000
Y54.0 Mineralocorticoids	0.579	0.421	0.000
G37.9 Demyelinating disease of central nervous system, unspecified	0.578	0.422	0.000
G91 Hydrocephalus	0.577	0.423	0.000
F11 Mental and behavioural disorders due to use of opioids	0.576	0.423	0.000
K67 Disorders of peritoneum in infectious diseases classified elsewhere	0.576	0.424	0.000
W01.1 Residential institution	0.576	0.424	0.000
K76.8 Other specified diseases of liver	0.576	0.424	0.000
L75 Apocrine sweat disorders	0.574	0.426	0.000
L74 Eccrine sweat disorders	0.574	0.426	0.000
L68 Hypertrichosis	0.574	0.426	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations